Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 1/28/2025 | $23.00 | Outperform | Evercore ISI | |
| 12/20/2024 | $20.00 | Buy | Chardan Capital Markets | |
| 12/11/2024 | Buy | TD Cowen | ||
| 10/14/2024 | $20.00 | Outperform | Leerink Partners | |
| 7/24/2024 | $36.00 | Buy | ROTH MKM | |
| 7/17/2024 | Speculative Buy | Canaccord Genuity | ||
| 5/29/2024 | $27.00 | Outperform | Robert W. Baird | |
| 4/15/2024 | $20.00 | Outperform | Leerink Partners |
4 - Canopy Growth Corp (0001737927) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Canopy Growth Corp (0001737927) (Issuer)
SUPPL - AURORA CANNABIS INC (0001683541) (Filer)
F-X - AURORA CANNABIS INC (0001683541) (Subject)
10-Q - IGC Pharma, Inc. (0001326205) (Filer)
ATHENS, Ga., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Terrapin Beer Co., a Tilray Beverages craft beer brand under Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), is excited to announce the 20th anniversary of its Wake-n-Bake Coffee Oatmeal Imperial Stout seasonal beer and the annual Wake-n-Bake Off event on Sunday, January 26th, 2025, at the Terrapin taproom in Athens, GA. In celebration of its 20th anniversary, guests will have the chance to observe local restaurants competing to craft the finest dish featuring Terrapin's renowned Wake-n-Bake Beer. This event highlights culinary innovation and fosters community engagement through an array of sweet and savory tastings that showcase the rich flavor
POTOMAC, MD / ACCESS Newswire / January 21, 2025 / IGC Pharma, Inc. (NYSE:IGC) ("IGC Pharma" or the "Company") is pleased to announce the appointment of Terry McAuliffe, the 72nd Governor of Virginia, as a strategic advisor. Governor McAuliffe's extensive leadership experience across public and private sectors will play a pivotal role in advancing IGC Pharma's mission to redefine Alzheimer's care and position the Company for growth in the biotechnology and pharmaceutical industries. As strategic advisor, Governor McAuliffe will focus on refining IGC Pharma's growth strategies, driving business development initiatives, and fostering partnerships with leading pharmaceutical and healthcare o
A cannabis and beverage alcohol industry executive with more than 25 years of experience, Mr. Jorgensen will lead the unified Canopy USA organization forward with a focus on driving profitable growth across the U.S. With the completed acquisitions of Acreage, Wana, and Jetty, Canopy USA now enters a new chapter of growth across key segments including flower, edibles, vapes, extracts, and through an established retail presence in high potential markets across the Midwest and Northeast BOULDER, Colo., January 6, 2025 /PRNewswire/ - Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the fastest growing states and highest potential segments of the U.S. c
SC 13G/A - Mind Medicine (MindMed) Inc. (0001813814) (Subject)
SC 13D/A - IGC Pharma, Inc. (0001326205) (Subject)
SC 13D - IGC Pharma, Inc. (0001326205) (Subject)
Evercore ISI initiated coverage of MindMed with a rating of Outperform and set a new price target of $23.00
Chardan Capital Markets initiated coverage of MindMed with a rating of Buy and set a new price target of $20.00
TD Cowen initiated coverage of Aurora Cannabis with a rating of Buy
NASDAQ | TSX: ACB Largest Global Medical Cannabis Company Operating in Nationally Regulated Markets, Aurora Removes Concession Card Requirements to Access IndiMed Products in Australia EDMONTON, AB, Feb. 14, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently removed the concession card requirement for patients to access medical cannabis products under the Company's IndiMed brand. By removing this eligibility barrier, any patient in Australia can now be prescribed IndiMed products, providing greater patient access to high quality medical can
A roundup of the most newsworthy press releases from Cision Distribution this week TORONTO, Feb. 14, 2025 /CNW/ - With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that
Together with Blue Sourberry and Altitude Lemon Lime, Deep Space Propulsion Continues to Pioneer the High-Potency Cannabis Beverage Category with its Expanded Portfolio of Innovative Flavours SMITHS FALLS, ON, Feb. 13, 2025 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today the expansion of its Deep Space Propulsion beverage lineup with two new flavours: Rocket Root Beer and Charged Cream Soda. Proudly developed in Canada, these innovative takes on classic flavours join Blue Sourberry and Altitude Lemon Lime, rounding out a portfol
4 - Mind Medicine (MindMed) Inc. (0001813814) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - IGC Pharma, Inc. (0001326205) (Issuer)
A roundup of the most newsworthy press releases from Cision Distribution this week TORONTO, Feb. 14, 2025 /CNW/ - With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that
Strong holiday sales drove Storz & Bickel net revenue growth of 19% year-over-year Record quarter for Canada medical cannabis with net revenue increasing 16%; international markets cannabis net revenue grew 14% year-over-year Successfully launched Claybourne infused pre-rolls across Canada, Claybourne rose to #3 market share in the infused pre-roll category in British Columbia and Ontario after 6 weeks in market1 SMITHS FALLS, ON, Feb. 7, 2025 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announces its financial results for the third fiscal quarter ended December 31, 2024 ("Q3 FY2025"). All financial information in this press
NASDAQ | TSX: ACB Reports Total Net Revenue1 of $88.2 Million, up 37% YoY, Including Record Net Revenue1 of $68.1 Million in Global Medical Cannabis, up 51% YoYGenerates Record Net Income of $31.2 Million, up 282% YoY, and Record Adjusted EBITDA1 of $23.1 Million, up 316% YoYAchieves Target of Positive Free Cash Flow1 in Q3, Generating $27.4 Million of Free Cash Flow1Maintains Strong Balance Sheet with $180 Million of Cash and Debt-Free Cannabis Business2EDMONTON, AB, Feb. 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third qu